Mon panier

LTBR

LTBR Informations sur la molécule

Nom anglaisTumor necrosis factor receptor superfamily member 3Nombre de médicaments commercialisés0
Nombre de médicaments cliniques1Alias de la cibleLymphotoxin-beta receptor,Tumor necrosis factor receptor type III,LTBR,Tumor necrosis factor receptor superfamily member 3,D12S370,TNFRSF3,TNFCR,TNFR3,TNFR Superfamily, Member 3,Lymphotoxin B Receptor,LT-BETA-R,TNF-R-III,TNFR2-RP,TNF-RIII,TNFR-III,TNFR-RP,Lymphotoxin beta Receptor,Tumor necrosis factor C receptor,Tumor Necrosis Factor Receptor 2-Related Protein,Lymphotoxin Beta Receptor (TNFR Superfamily, Member 3)
Phase de R&D la plus avancéePhase 1 Clinical
Nom anglaisTumor necrosis factor receptor superfamily member 3
Alias de la cibleLymphotoxin-beta receptor,Tumor necrosis factor receptor type III,LTBR,Tumor necrosis factor receptor superfamily member 3,D12S370,TNFRSF3,TNFCR,TNFR3,TNFR Superfamily, Member 3,Lymphotoxin B Receptor,LT-BETA-R,TNF-R-III,TNFR2-RP,TNF-RIII,TNFR-III,TNFR-RP,Lymphotoxin beta Receptor,Tumor necrosis factor C receptor,Tumor Necrosis Factor Receptor 2-Related Protein,Lymphotoxin Beta Receptor (TNFR Superfamily, Member 3)
Nombre de médicaments commercialisés0
Nombre de médicaments cliniques1
Phase de R&D la plus avancéePhase 1 Clinical

LTBR Liste de produits

  • Attribut

    Protein (5)

  • Bibliothèque de produits

    En ligne (5)

  • Espèces

    Human (3)Cynomolgus (1)Mouse (1)

  • Étiquette

    His Tag & Avi Tag (2)Fc Tag (1)His Tag (2)

  • Marqueur

    Biotin-labeled (1)Unconjugated (4)

LTBRContexte de la molécule

Lymphotoxin-beta receptor (LTBR) is also known as Tumor necrosis factor receptor superfamily member 3 (TNFRSF3), Tumor necrosis factor receptor type III (TNF-RIII), which is a single-pass type I membrane protein containing four TNFR-Cys repeat regions. Except for interacting with HCV core protein, LTBR can not only associate with itself, but also can associate with TRAF3, TRAF4 and TRAF5. As the receptor for the heterotrimeric lymphotoxin containing LTA and LTB, and for TNFS14/LIGHT, LTBR promotes apoptosis via TRAF3 and TRAF5. Furthermore, LTBR may play a role in the development of lymphoid organs.

LTBRAlias de la molécule

LTBR,D12S370,TNFCR,TNFR3,TNFRSF3,TNFRIII

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
RO-7567132RO7567132; RO-7567132; RG-6221; RG6221Phase 1 ClinicalF. Hoffmann-La Roche AgNeoplasms; Solid tumours
Details
  • Informations sur la molécule
  • Liste de produits
  • Informations sur les médicaments cliniques